Searchable abstracts of presentations at key conferences in endocrinology

ea0019s15 | Calcium conundrums: too high, too low and what to do | SFEBES2009

Diagnosis and management of post-operative hypocalcaemia following (para)thyroidectomy

Gittoes NJL

With limited UK health resources and a drive to minimise risk of hospital-acquired infections, there is continual striving to reduce length of stay for all in patient procedures. Increasing numbers of elective surgical procedures are carried out as day cases. Many centres adopt minimally invasive parathyroidectomy (carried out as a day case) as the preferred treatment for primary hyperparathyroidism and there is pressure to minimise post-operative length of stay following thyr...

ea0011p616 | Neuroendocrinology and behaviour | ECE2006

Rate of change in size of macroprolactinomas with dopamine agonist therapy – is there any relationship to fall in prolactin concentrations?

Miller CL , Palalau A , Toogood AA , Gittoes NJL

The most effective means of treating macroprolactinomas, including those associated with significant visual loss at presentation, is with dopamine agonist (DA) therapy. Improvement in visual function often occurs within days of commencing DA therapy, and usually precedes significant reductions in prolactin (PRL) concentrations and may predate significant evidence of tumour volume reduction by months or years. The temporal association between PRL concentration reductions and tu...